New Students Offer - Use Code HELLO

Register Now

Pfizer acquires Seagen for cancer treatment development

Published on March 14, 2023
Current context: Pfizer will spend 43 billion dollar to buy Seagen for cancer research development. Pfizer will pay 229 dollar per share to Seagen.
Pfizer acquires Seagen for cancer treatment development
  • Both the companies will collaborate to provide Seagen’s antibody drug conjugate (ADC) with the help of Pfizer’s expertise in the field.
  • Seagen is a Washington based company which is a biotech drug developer. It mainly specializes in cancer treatment.
  • Seagen’s top seller, Adcertis, also made a deal with Pfizer’s Array BioPharma to treat breast cancer.
  • Pfizer is a New York based company, has also contributed 11.6 billion dollars to migraine treatment developer Biohaven Pharmaceuticals.
  • Pfizer concludes that Seagen can provide more than 10 billion dollars revenue until 2030 in the field of cancer treatment.


Q.1 Pfizer has collaborated with_______ for cancer treatment development.
c. Seagen
d. IIT Kanpur

Can I help you?

ramandeep singh

Hey I am Ramandeep Singh. I am determined to help students preparing for RBI, SEBI, NABARD and IBPS exams. Do you want me to help you ?

Join my class here
    Follow me:
Close Menu
Close Menu